OrthoPediatrics (NASDAQ:KIDS) Stock Price Down 4.2% – Time to Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS) traded down 4.2% on Tuesday . The stock traded as low as $23.39 and last traded at $23.96. 60,941 shares were traded during trading, a decline of 78% from the average session volume of 275,512 shares. The stock had previously closed at $25.00.

Wall Street Analyst Weigh In

Several brokerages recently commented on KIDS. Truist Financial cut their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Tuesday.

OrthoPediatrics Trading Down 8.1 %

The business’s 50 day moving average price is $24.20 and its 200-day moving average price is $27.41. The firm has a market capitalization of $556.48 million, a price-to-earnings ratio of -18.68 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

Hedge Funds Weigh In On OrthoPediatrics

Several hedge funds have recently added to or reduced their stakes in KIDS. Quarry LP purchased a new stake in OrthoPediatrics in the third quarter valued at approximately $25,000. International Assets Investment Management LLC grew its position in OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC purchased a new stake in OrthoPediatrics during the second quarter valued at about $34,000. BNP Paribas Financial Markets increased its stake in OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after acquiring an additional 1,929 shares during the last quarter. Finally, Quantbot Technologies LP lifted its stake in shares of OrthoPediatrics by 42.2% in the 3rd quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock valued at $157,000 after purchasing an additional 1,712 shares in the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.